KeyCorp Has Positive Estimate for InnovAge Q4 Earnings

InnovAge Holding Corp. (NASDAQ:INNV) – Analysts at KeyCorp upped their Q4 2026 earnings estimates for shares of InnovAge in a research note issued to investors on Thursday, August 20th. KeyCorp analyst M. Gillmor now forecasts that the company will earn $0.09 per share for the quarter, up from their prior estimate of $0.07. KeyCorp has a “Overweight” rating and a $13.00 price target on the stock. The consensus estimate for InnovAge’s current full-year earnings is $0.07 per share. KeyCorp also issued estimates for InnovAge’s Q1 2027 earnings at $0.11 EPS, Q2 2027 earnings at $0.11 EPS, Q3 2027 earnings at $0.15 EPS, Q4 2027 earnings at $0.09 EPS and FY2027 earnings at $0.47 EPS.

Several other research analysts have also recently weighed in on the company. Wall Street Zen cut InnovAge from a “buy” rating to a “hold” rating in a research report on Sunday, May 17th. Weiss Ratings reissued a “sell (d-)” rating on shares of InnovAge in a research report on Thursday, August 13th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Reduce” and an average price target of $10.00.

InnovAge Stock Performance

INNV opened at $11.02 on Monday. The company has a market capitalization of $1.50 billion, a price-to-earnings ratio of -122.44 and a beta of 0.39. The business’s 50-day moving average price is $11.00 and its two-hundred day moving average price is $9.12. InnovAge has a 1 year low of $3.54 and a 1 year high of $12.64. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.03 and a quick ratio of 1.03.

Institutional Investors Weigh In On InnovAge

Several institutional investors and hedge funds have recently added to or reduced their stakes in INNV. Deutsche Bank AG boosted its stake in shares of InnovAge by 15.1% during the 4th quarter. Deutsche Bank AG now owns 12,775 shares of the company’s stock worth $66,000 after buying an additional 1,679 shares during the last quarter. Legal & General Group Plc acquired a new stake in shares of InnovAge in the second quarter valued at about $25,000. Kathmere Capital Management LLC increased its position in shares of InnovAge by 17.0% in the first quarter. Kathmere Capital Management LLC now owns 15,534 shares of the company’s stock valued at $125,000 after acquiring an additional 2,260 shares during the last quarter. California State Teachers Retirement System raised its holdings in InnovAge by 207.3% during the second quarter. California State Teachers Retirement System now owns 3,365 shares of the company’s stock worth $40,000 after acquiring an additional 2,270 shares in the last quarter. Finally, Barclays PLC raised its holdings in InnovAge by 10.6% during the fourth quarter. Barclays PLC now owns 31,591 shares of the company’s stock worth $164,000 after acquiring an additional 3,040 shares in the last quarter. 12.26% of the stock is owned by institutional investors.

InnovAge Company Profile

InnovAge Holdings, Inc (NASDAQ:INNV) is a healthcare services company that specializes in caring for seniors through the Program of All-Inclusive Care for the Elderly (PACE). Designed for individuals who are eligible for both Medicare and Medicaid, the PACE model integrates medical care, social services and long-term care—delivered primarily in participants’ homes and community-based centers. InnovAge’s approach centers on interdisciplinary care teams that coordinate everything from primary and specialty medical services to nutritional counseling and recreational activities.

The company’s core offerings include comprehensive in-home assessments, physician and nursing services, physical and occupational therapy, prescription medication management, and transportation to medical appointments.